SOMERSET, N.J. - June 4, 2020 - Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that John Chiminski, Chair and Chief Executive Officer, will join other R&D leaders to present during BIO Digital, which will take place on June 8 - 12, 2020. On Tuesday, June 9 at 10 a.m. EDT, Mr. Chiminski will participate in the `Endpoints at BIO20` panel session, titled, `R&D Leadership During the Pandemic`. He will join panelists from Amgen, GlaxoSmithKline, Johnson & Johnson and Takeda to discuss the structures they have put in place at their...
|
